Naloxona B. Braun (Naloxone Hydrochloride)

Naloxone Hydrochloride, the active ingredient in Naloxona B. Braun, is an opioid antagonist presented as an injectable solution for intramuscular and intravenous use. It rapidly reverses the effects of opioid overdose in emergency situations. GNH USA supplies Naloxona B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naloxona B. Braun is an opioid antagonist used in acute care to counteract opioid toxicity. - Opioid overdose: rapid reversal of life‑threatening respiratory depression. - Opioid‑induced respiratory depression: restores normal breathing in emergency settings. - Opioid toxicity in trauma or surgery: reestablishes consciousness and airway protection.

Naloxona B. Braun may cause a range of adverse reactions following administration.

Common Side Effects: - Nausea - Vomiting - Sweating - Headache - Agitation or anxiety - Increased blood pressure - Tachycardia

Serious or Rare Side Effects: - Severe hypertension - Pulmonary edema - Seizures - Allergic reactions (rash, urticaria) - Anaphylaxis - Cardiac arrhythmias

Naloxona B. Braun requires careful clinical assessment before use. - Assess airway and breathing: ensure ventilation support is available before administration. - Check for opioid dependence: may precipitate acute withdrawal symptoms. - Avoid in patients with known hypersensitivity to naloxone or formulation excipients. - Use with caution in cardiovascular disease: may cause abrupt hypertension. - Monitor vital signs after dosing: watch for recurrent respiratory depression. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Naloxona B. Braun can interact with other substances that affect the central nervous system or cardiovascular function.

Major Interactions (Avoid): - Opioid agonists administered concurrently: may reduce reversal effectiveness. - Monoamine oxidase inhibitors: risk of severe hypertension when combined with naloxone.

Moderate Interactions (Monitor Closely): - Benzodiazepines: may require additional respiratory support. - Alcohol: can potentiate central nervous system depression after naloxone wears off. - Beta‑blockers: may mask tachycardia that signals withdrawal.